novel treatment strategies in low-risk mds: case study
Published 2 years ago • 184 plays • Length 18:42Download video MP4
Download video MP3
Similar videos
-
18:14
novel treatment strategies in low-risk mds: challenges and emerging therapies
-
14:55
novel treatment strategies in low-risk mds: q&a
-
21:55
a unified approach to lower risk mds: standard and emerging therapies
-
29:39
novel strategies to prevent relapse after allogeneic transplantation for mds
-
24:04
my approach to mds management
-
1:25
novel strategies for treating cytopenia in mds
-
25:10
management of lower-risk mds without del5q and refractory to esas
-
10:11
novel agents and treatment strategies in myelodysplastic syndromes
-
1:27
novel targets in low-risk mds
-
1:34
managing adverse events with novel therapies in lower-risk mds
-
4:12
novel therapies in low-risk mds
-
14:26
why, when, and how to use iron chelation therapy in mds
-
24:10
when hma fails: newer therapeutic agents for mds
-
1:38
novel treatment options for lr-mds and the importance of clinical trials in this space
-
19:11
novel agents and combination therapies in myelofibrosis
-
22:08
a unified approach to higher risk mds: standard and emerging therapies
-
1:22:25
low-risk mds: can we prevent progression?
-
3:38
a new set of treatment options for low-risk mds